ME 2303
Alternative Names: FAD 104; FT-ADMLatest Information Update: 28 Nov 2000
At a glance
- Originator Meiji Seika Kaisha
- Class Cytostatic antibiotics
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Nov 2000 No-Development-Reported for Cancer in Japan (Unknown route)
- 18 May 1995 Phase-II clinical trials for Cancer in Japan (Unknown route)